Core Patient-Reported Outcomes (PROs) and PRO Measures (PROMs) for Polypharmacy Medicines Reviews: A Sequential Mixed-Methods Study

References

• Johnston MC, Crilly M, Black C, Prescott GJ, Mercer SW. Defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health. 2019;29(1):182–189. doi:10.1093/eurpub/cky09829878097
   PubMed Web of Science ®Google Scholar
• Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound. Kings Fund. 2013 doi:10.1136/bmjopen-2013-002913
   Google Scholar
• Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13(1):1–10. doi:10.1186/s12916-015-0322-725563062
   PubMed Web of Science ®Google Scholar
• Barrett K, Lucas E, Alexander GC. How polypharmacy has become a medical burden worldwide. Clin Pharm. 2016;8(6). doi:10.1211/CP.2016.20201251
   Google Scholar
• Cadogan CA, Ryan C, Hughes CM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Saf. 2016;39:109–116. doi:10.1007/s40264-015-0378-526692396
   PubMed Web of Science ®Google Scholar
• Eton D, Ridgeway J, Egginton J, et al. Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions. Patient Relat Outcome Meas. 2015;6:117–126. doi:10.2147/PROM.S7895525848328
   PubMedGoogle Scholar
• Sav A, King MA, Whitty JA, et al. Burden of treatment for chronic illness: a concept analysis and review of the literature. Heal Expect. 2015;18(3):312–324. doi:10.1111/hex.12046
   PubMed Web of Science ®Google Scholar
• Katusiime B, Corlett S, Reeve J, Krska J. Measuring medicine-related experiences from the patient perspective: a systematic review. Patient Relat Outcome Meas. 2016;7:157–171. doi:10.2147/PROM.S10219827785116
   PubMedGoogle Scholar
• Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. doi:10.1016/S0140-6736(12)60240-222579043
   PubMed Web of Science ®Google Scholar
• Payne RA. The epidemiology of polypharmacy. Clin Med J R Coll Physicians London. 2016;16(5):465–469. doi:10.7861/clinmedicine.16-5-465
   Google Scholar
• Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–1169. doi:10.1007/s11096-013-9841-523990332
   PubMed Web of Science ®Google Scholar
• Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. “I don’t know how many of these [medicines] are necessary.”-A focus group study among elderly users of multiple medicines. Patient Educ Couns. 2009;74(2):135–141. doi:10.1016/j.pec.2008.08.01918845412
   PubMed Web of Science ®Google Scholar
• Eton D, Elraiyah TA, Yost K, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20. doi:10.2147/PROM.S4469423833553
   PubMedGoogle Scholar
• Beuscart JB, Knol W, Cullinan S, et al. International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med. 2018;16:21. doi:10.1186/s12916-018-1007-929433501
   PubMed Web of Science ®Google Scholar
• Beuscart JB, Pont LG, Thevelin S, et al. A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set. Br J Clin Pharmacol. 2017;83:942–952. doi:10.1111/bcp.1319727891666
   PubMed Web of Science ®Google Scholar
• Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing. Scottish Government. 2018 Available from: https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/09/Polypharmacy-Guidance-2018.pdf. Accessed 1220, 2018.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21_1):b2535. doi:10.1136/bmj.b253519622551
   PubMed Web of Science ®Google Scholar
• Khangura S, Konnyu K, Cushman R, Grimshaw J, Moher D. Evidence summaries: the evolution of a rapid review approach. Syst Rev. 2012;1:10. doi:10.1186/2046-4053-1-1022587960
   PubMedGoogle Scholar
• Mokkink L, Prinsen C, Patrick D, et al. COSMIN methodology for systematic reviews of Patient‐Reported Outcome Measures (PROMs): user manual. Amsterdam Public Health Research Institute. 2018 Available from: https://www.cosmin.nl/wp-content/uploads/COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018-1.pdf. Accessed 430, 2019.
   Google Scholar
• Maguire M, Delahunt B. Doing a thematic analysis: a practical, step-by-step guide for learning and teaching scholars. Irel J Teach Learn High Educ. 2017;8(3):3351–33514.
   Google Scholar
• Carter SR, Bulanadi MG, Katusiime B, Chen TF, Corlett S, Krska J. Comprehensibly measuring patients’ subjective thoughts, feelings and experiences of living with medicines: the Living with Medicines Questionnaire (LMQ). Int J Clin Pharm. 2015;37:424–425. doi:10.1007/s11096-015-0080-9
   Web of Science ®Google Scholar
• Krska J, Morecroft CW, Rowe PH, Poole H. Measuring the impact of long-term medicines use from the patient perspective. Int J Clin Pharm. 2014;36(4):675–678. doi:10.1007/s11096-014-9970-524997013
   PubMed Web of Science ®Google Scholar
• Krska J, Katusiime B, Corlett SA. Validation of an instrument to measure patients’ experiences of medicine use: the living with medicines questionnaire. Patient Prefer Adherence. 2017;11:671–679. doi:10.2147/PPA.S12664728405159
   PubMed Web of Science ®Google Scholar
• Katusiime B, Corlett S, Krska J. Development and validation of a revised instrument to measure burden of long-term medicines use: the living with medicines questionnaire version 3. Patient Relat Outcome Meas. 2018;9:155–168. doi:10.2147/prom.s15114329881317
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2(1):12. doi:10.1186/1477-7525-2-1214987333
   PubMedGoogle Scholar
• Atkinson MJ, Kumar R, Cappelleri JC, Mass SL. Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM version II) among outpatient pharmacy consumers. Value Heal. 2005;8(Suppl 1):S9–S24. doi:10.1111/j.1524-4733.2005.00066.x
   PubMed Web of Science ®Google Scholar
• Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm. 2013;35(1):51–56. doi:10.1007/s11096-012-9704-523054137
   PubMed Web of Science ®Google Scholar
• Reeve E, Low LF, Shakib S, Hilmer SN. Development and validation of the Revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913–928. doi:10.1007/s40266-016-0410-127785734
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Heal. 1999;14(1):1–24. doi:10.1080/08870449908407311
   Web of Science ®Google Scholar
• Berman RL, Iris M, Conrad KJ, Robinson C. Validation of the MedUseQ: a self-administered screener for older adults to assess medication use problems. J Pharm Pract. 2018;8971900187. doi:10.1177/0897190018766789
   Web of Science ®Google Scholar
• Mohammed MA, Moles RJ, Hilmer SN, Kouladjian O’Donnel L, Chen TF. Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool. BMJ Open. 2018;8:e018880. doi:10.1136/bmjopen-2017-018880
   Web of Science ®Google Scholar
• Eton DT, Yost KJ, Lai JS, et al. Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden. Qual Life Res. 2017;26(2):489–503. doi:10.1007/s11136-016-1397-027566732
   PubMed Web of Science ®Google Scholar
• Linsky A, Simon SR, Stolzmann K, Meterko M. Patient perceptions of deprescribing: survey development and psychometric assessment. Med Care. 2017;55(3):306–313. doi:10.1097/MLR.000000000000064227579916
   PubMed Web of Science ®Google Scholar
• Williams B, Shaw A, Durrant R, Crinson I, Pagliari C, de Lusignan S. Patient perspectives on multiple medications versus combined pills: a qualitative study. QJM. 2005;98(12):885–893. doi:10.1093/qjmed/hci13916284068
   PubMed Web of Science ®Google Scholar
• Kamaradova D, Latalova K, Prasko J, et al. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence. 2016;10:1289–1298. doi:10.2147/PPA.S9913627524884
   PubMed Web of Science ®Google Scholar
• Nelson E, Werremeyer A, Kelly GA, Skoy E. Self-stigma of antidepressant users through secondary analysis of PhotoVoice data. Ment Heal Clin. 2018;8(5):214–221. doi:10.9740/mhc.2018.09.214
   Google Scholar
• Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010;67(1):26–36. doi:10.1001/archgenpsychiatry.2009.17520048220
   PubMed Web of Science ®Google Scholar
• Gupta S, Cahill JD. A prescription for “deprescribing” in psychiatry. Psychiatr Serv. 2016;67(8):904–907. doi:10.1176/appi.ps.20150035926975524
   PubMed Web of Science ®Google Scholar
• Johnston B, Flemming K, Narayanasamy MJ, Coole C, Hardy B. Patient reported outcome measures for measuring dignity in palliative and end of life care: a scoping review. BMC Health Serv Res. 2017;17:574. doi:10.1186/s12913-017-2450-628830441
   PubMed Web of Science ®Google Scholar